Loading

Editorial Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.33696/immunology.1.001

Deubiquitinase as Potential Targets for Cancer Immunotherapy

  • 1Department of Immunology, The University of Texas MD Anderson Cancer Center, 7455 Fannin Street, Houston TX 77030, USA
+ Affiliations - Affiliations

Corresponding Author

Xiaoping Xie, xxie5@mdanderson.org

Received Date: January 27, 2019

Accepted Date: January 28, 2019

Author Information X